TG Therapeutics, Inc. (BIT:1TGTX)

TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.13	179.89	92.93	102.3	298.89	553.44
Short-Term Investments	122.74	131.11	124.58	59.37	15.88	51.99
Cash & Short-Term Investments	251.87	311	217.51	161.68	314.76	605.43
Cash Growth	15.93%	42.98%	34.53%	-48.63%	-48.01%	331.11%
Accounts Receivable	231.52	129.19	51.09	-	1.39	-
Inventory	155.2	110.46	39.82	-	-	-
Other Current Assets	25.37	15.72	9.52	6.6	14.81	6.31
Total Current Assets	663.96	566.36	317.94	168.27	330.97	611.74
Net Property, Plant & Equipment	6.72	7.15	8.05	10.82	11.07	11.84
Goodwill	-	-	-	0.8	0.8	0.8
Long-Term Investments	28.59	0.81	-	12.4	35.53	-
Other Long-Term Assets	3.34	3.37	3.59	1.27	1.26	1.26
Total Assets	702.61	577.69	329.59	193.57	379.63	625.64
Accounts Payable	134.02	58.3	38.47	42.02	51.29	37.01
Accrued Expenses	10.61	15.19	12.17	8.43	10.17	8.46
Current Portion of Long-Term Debt	-	-	-	-	0.98	22.18
Current Portion of Leases	1.09	1.16	1.45	1.58	1.44	1.67
Unearned Revenue	23.91	11.41	0.15	-	-	-
Other Current Liabilities	2.26	4.63	1.48	1.17	1.51	18.24
Total Current Liabilities	171.89	90.68	53.72	53.2	65.38	87.55
Long-Term Debt	245.04	244.43	100.12	71.14	66.79	7.72
Long-Term Leases	7.59	8.13	9.23	10.34	9.85	10.41
Other Long-Term Liabilities	1.67	12.09	6.02	0.31	0.46	0.61
Total Long-Term Liabilities	254.29	264.65	115.37	81.78	77.09	18.74
Total Liabilities	426.18	355.33	169.09	134.99	142.48	106.29
Common Stock	0.16	0.16	0.15	0.15	0.14	0.14
Treasury Stock	-21.99	-8.99	-0.23	-0.23	-0.23	-0.23
Additional Paid-in Capital	1,794	1,760	1,713	1,586	1,566	1,500
Retained Earnings	-1,496	-1,529	-1,553	-1,527	-1,329	-980.6
Shareholders' Equity	276.43	222.36	160.5	58.59	237.15	519.35
Total Liabilities & Equity	702.61	577.69	329.59	193.57	379.63	625.64
Total Debt	253.72	253.72	110.8	83.06	79.05	41.98
Net Cash (Debt)	-1.85	57.28	106.71	78.62	235.72	563.45
Net Cash Growth	-	-46.32%	35.74%	-66.65%	-58.17%	465.54%
Net Cash Per Share	-0.01	0.36	0.72	0.58	1.78	4.88
Book Value	276.43	222.36	160.5	58.59	237.15	519.35
Book Value Per Share	1.71	1.39	1.08	0.43	1.79	4.50
Tangible Book Value	276.43	222.36	160.5	57.79	236.35	518.55
Tangible Book Value Per Share	1.71	1.39	1.08	0.43	1.79	4.50

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.